Prevalence and clinical correlates of liver function test abnormalities in acute heart failure
Authors:
- Olumide Akinniyi AkinyeleOAOlumide Akinniyi Akinyele
- Rasaaq Ayodele AdebayoRARasaaq Ayodele Adebayo
- Michael Olabode BalogunMBMichael Olabode Balogun
- Anthony Olubunmi AkintomideAAAnthony Olubunmi Akintomide
- Oladipo Ayoola OlanipekunOOOladipo Ayoola Olanipekun
- Obafemi Sunday AdesanyaOAObafemi Sunday Adesanya
- Busayo Onafowoke OguntolaBOBusayo Onafowoke Oguntola
Open Access
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 11
Abstract
Background: In Africa, heart failure is an important cause of death. In acute heart failure (AHF) liver function test (LFT) abnormalities have been shown to be widespread in the industrialized nations and to be somewhat linked to adverse outcomes. However, there is sparse information regarding abnormalities of LFT in AHF within Africa, particularly in the West-African sub-region, which includes Nigeria, the continents most populated nation. This study sought to determine the prevalence and clinical associations of abnormalities of LFT among Nigerian patients hospitalized with AHF. Methods: In a prospective study we enrolled 100 volunteers, 50 of them were admitted AHF patients, and 50 were sex and age matched healthy controls. Participants were recruited consecutively after giving informed consent. All underwent laboratory blood testing for six LFT parameters - alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), albumin, and total bilirubin – and echocardiographic assessment. Those with pre-existing liver disease were excluded. Associations between LFT abnormalities, clinical, and echocardiographic parameters were analyzed. Results: All AHF patients demonstrated at least one LFT abnormality (100%). Hypoalbuminemia (78%) and elevated GGT (74%) were most common [others: elevated ALP-10%, elevated ALT-18%, elevated AST-60%, and elevated total bilirubin-22%]. There was significant negative correlation between ALT, AST, ALP, Total bilirubin, and blood pressure (both systolic and diastolic). Low systolic blood pressure (BP) was associated with elevated ALT and ALP; both p = 0.003. Low diastolic blood pressure was associated with elevated ALT, AST (transaminases), and total bilirubin; p < 0.001, p = 0.002, and p = 0.006, respectively. Ankle edema was associated with elevated GGT; p = 0.007. Ascites was associated with hypoalbuminemia; p = 0.002. High right atrial pressure was associated with elevated GGT and hypoalbuminemia; p = 0.008 and p = 0.042, respectively. Heart failure with reduced ejection fraction (HFrEF) was associated with elevated total bilirubin; p = 0.043. E/e’ >14 and grade III LV diastolic dysfunction were associated with hypoalbuminemia; both p = 0.004. Conclusion: LFT abnormalities were universal among Nigerian patients with AHF, and associated with distinct pathophysiological mechanisms: hypoperfusion (elevated transaminases and bilirubin), systemic congestion (elevated GGT, hypoalbuminemia), and left ventricular dysfunction (elevated bilirubin in systolic dysfunction, hypoalbuminemia in diastolic dysfunction). Routine LFT assessment may provide inexpensive, clinically useful insights that may guide therapy in AHF, particularly in resource-limited settings.Keywords
This publication has 31 references indexed in Scilit:
- Hypoalbuminaemia and Heart Failure: A Practical Review of Current EvidenceEuropean Journal of Heart Failure, 2024
- Looking at the Heart Failure Through the Prism of Liver DysfunctionEuropean Journal of Heart Failure, 2020
- Epidemiology of Heart FailureEuropean Journal of Heart Failure, 2020
- Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)The American Journal of Cardiology, 2020
- Comprehensive In-Hospital Monitoring in Acute Heart Failure: Applications for Clinical Practice and Future Directions for Research. A Statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2018
- Do Patients have Worse Outcomes in Heart Failure Than in Cancer? A Primary Care-Based Cohort Study with 10-Year Follow-Up in ScotlandEuropean Journal of Heart Failure, 2017
- Abnormal Liver Function Tests in Acute Heart Failure: Relationship with Clinical Characteristics and Outcome in the PROTECT StudyEuropean Journal of Heart Failure, 2016
- Liver Function Tests in Patients with Acute Heart Failure and Associated Outcomes: Insights from ASCEND-HFEuropean Journal of Heart Failure, 2015
- Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure PatientsJournal of Cardiac Failure, 2010
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976